Table 1. Baseline characteristics in waitlisted candidates without diabetes or cardiovascular disease (Groups 1 & 2) according to NISS status.

		Stress Test		P
		No	Yes
		Group 1	Group 2
		(n = 255)	(n = 368)
Age: years		36.7 (11.1)	54.1 (11.8)	< 0.001
BMI		26.0 (4.5)	26.8 (4.9)	0.04
Male (%)		152 (59.6)	191 (51.9)	0.06
Hypertension (%)		209 (82.0)	327 (88.9)	0.02
Non-Smoker (%)		189 (74.1)	210 (57.1)	< 0.001
Ethnicity (%)	Caucasian	197 (77.3)	293 (79.6)	0.48
Primary Disease (%)	Immune Kidney Disease	71 (27.8)	117 (31.8)	<0.01
	Hypertensive CKD	30 (11.8)	58 (15.8)
	Polycystic Kidney Disease	33 (12.9)	67 (18.2)
	Other	65 (47.5)	76 (34.3)
Previous Transplant (%)		32 (12.6)	56 (15.2)	0.35
Pre-emptive evaluation (%)		211 (82.8)	279 (75.8)	0.38
On Dialysis at evaluation (%)		44 (17.2)	89 (24.2)
Pulmonary Disease (%)		13 (5.1)	34 (9.2)	0.05
Peptic ulcer disease (%)		6 (2.4)	21 (5.7)	0.04
Liver Disease (%)		10 (3.9)	12 (3.3)	0.66
Previous Cancer (%)		8 (3.1)	27 (7.3)	0.03
HIV (%)		3 (1.2)	2 (0.5)	0.40
Charlson Comorbidity Index		2 (2,2)	2 (2, 3)	< 0.001
AHA risk factors (3 or more)		80 (31.4)	187 (50.8)	<0.001
RAS inhibitors (%)		168 (65.9)	210 (57.1)	0.03
Statin (%)		97 (38.0)	203 (55.2)	< 0.001
eGFR (ml/min/1.73m2)		12.3 (5.0)	11.6 (4.6)	0.08
Calcium (mmol/L)		2.3 (0.2)	2.3 (0.2)	0.36
Phosphate(mmol/L)		1.4 (1.2, 1.7)	1.4 (1.2, 1.7)	0.38
PTH (ng/L)		199 (116, 343)	200 (118, 355)	0.80
Albumin (g/L)		40.4 (5.9)	39.7 (5.6)	0.12
CRP (mg/L)		3.2 (1.4, 6)	5 (2.5, 8.2)	< 0.001
Total Cholesterol (mmol/L)		4.8 (4.0, 5.6)	4.6 (2.4, 11.6)	0.17
HDL Cholesterol (mmol/L)		1.2 (1.0, 1.5)	1.3 (1.1, 1.7)	0.03
Total / HDL Cholesterol (mmol/L)		3.8 (3.0, 4.7)	3.4 (2.8, 4.4)	<0.01

Results shown as Mean (Standard Deviation), Median (IQR) for continuous variables and Number (Frequency) for categorical variables.

p-Value from Two Sample T-Test, Mann-Whitney U Test and Chi-Squared or Fisher’s Exact test as appropriate.